Initial mechanistic studies of antisense targeting in cells

Journal of Nuclear Medicine

Volumn 47, Issue 2, 2006, Pages 360-368

  Liu, Xinrong ^a   Nakamura, Kayoko ^b   Wang, Yi ^a   Wang, Yee ^a   Liu, Guozheng ^a   He, Jiang ^a   Ding, Hongliu ^a   Lu, Peiyuan ^a   Rusckowski, Mary ^a   Kubo, Atsushi ^b   Hnatowich, Donald J ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antisense DNA; In situ transcription; mdr1 messenger RNA; Mechanism; Transcription rate

Indexed keywords

COMPLEMENTARY DNA; DNA; GLYCOPROTEIN P; MESSENGER RNA; RADIOISOTOPE; TECHNETIUM 99M; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; URIDINE TRIPHOSPHATE P 32;

ARTICLE; CYTOPLASM; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; ISOTOPE LABELING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; UPREGULATION; GENE TARGETING; GENETICS; METHODOLOGY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA, ANTISENSE; GENE TARGETING; HUMANS; P-GLYCOPROTEIN;

EID: 33746908696     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hnatowich DJ, Nakamura K. Antisense targeting in cell culture with radiolabeled DNAs: a brief review of recent progress. Ann Nucl Med. 2004;18:363-368.
2. Nakamura K, Fan C, Liu G, et al. Evidence of antisense tumor targeting in mice. Bioconjug Chem. 2004;15:1475-1480.
3. Nakamura K, Kubo A, Hnatowich DJ. Antisense targeting of P-glycoprotein expression in tissue culture. J Nucl Med. 2005;46:509-513.
4. 99mTc-labeled antisense DNA. J Nucl Med. 2001;42:1660-1669.
5. Winnard P Jr, Chang F, Rusckowski M, et al. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA. Nucl Med Biol. 1997;24:425-432.
6. 99mTc-labeled morpholino oligomers. Antisense Nucleic Acid Drug Dev. 2002;12:393-398.
7. Zhang YM, Liu N, Zhu ZH, et al. Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA. Eur J Nucl Med. 2000;27:1700-1707.
8. Politz JC, Singer RH. In situ reverse transcription for detection of hybridization between oligonucleotides and their intracellular targets. Methods. 1999;18:281-285.
9. Politz JC, Taneja KL, Singer RH. Characterization of hybridization between synthetic oligodeoxynucleotides and RNA in living cells. Nucleic Acids Res. 1995;23:4946-4953.
10. 99mTc-peptide-peptide nucleic acid-peptide chimeras. J Nucl Med. 2004;45:2070-2082.
11. Alahari SK, Delong R, Fisher MH, et al. Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression. J Pharmacol Exp Ther. 1998;286:419-428.
12. Crooke ST. Progress in antisense technology. Annu Rev Med. 2004;55:61-95.
13. Dias N, Stein CA. Antisense oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther. 2002;1:347-355.
14. Beltinger C, Saragovi HU, Smith RM, et al. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest. 1995;95:1814-1823.
15. Neary CL, Cho-Chung YS. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIα regulatory subunit. Oncogene. 2001;20:8019-8024.
16. Smith CW, Valcarcel J. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci. 2000;25:381-388.
17. Kole R, Vacek M, Williams T. Modification of alternative splicing by antisense therapeutics. Oligonucleotides. 2004;14:65-74.
18. Kole R, Williams T, Cohen L. RNA modulation, repair and remodeling by splice switching oligonucleotides. Acta Biochim Pol. 2004;51:373-378.
19. Karras JG, Mckay RA, Dean NM, et al. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-α chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing. Mol Pharmacol 2000;58:380-387.
20. Robb GB, Brown KM, Khurana J, et al. Specific and potent RNAi in the nucleus of human cells. Nat Struct Mol Biol. 2005;12:133-137.